Cannabis Law Report

JANUARY 30, 2019

To expand the number of manufacturers, the Drug Enforcement Administration (DEA) submitted a notice in the Federal Register on August 11, 2016, soliciting applications for licenses to manufacture marijuana for research purposes. Both DOJ and HHS agreed to conduct a medical and scientific evaluation of CBD independent of marijuana in 2015.

Research and Development 63

Research and Development DEA CBD Law 63

Connor & Connor PLLC

AUGUST 15, 2024

If Congress would like to change the legal status of marijuana, they would do so before or after the DEA makes a final scheduling decision. On May 21, 2024, the DEA opened a 62-day public comment period, which concluded on July 22, 2024. A crucial issue associated with state laws is that the state employment laws will not be modified.

Marijuana 52

Marijuana DEA Policy Business 52

Cannabis Law Report

MARCH 25, 2019

The Attorney General forwards the request to the Health and Human Services Secretary and requests a scientific and medical evaluation and recommendation, as specified by 23 USC 811(b-c). The DEA has made previous requests–in 2001 and 2006–to the FDA for an evaluation of marijuana. Emphasis added).

Banking 45

Banking Law Marijuana State Laws 45

Veriheal

NOVEMBER 7, 2024

The Drug Enforcement Administration (DEA) announced in August that a hearing regarding the reclassification decision will take place on December 2, 2024, before an administrative law judge. After the hearing concludes, the administrative law judge will compile a report based on the testimony given.

DEA 97

DEA Policy Chronic Pain Marijuana 97